Login to Your Account



Amgen Earnings Beat Estimates, But ESA Uncertainty Looms

By Trista Morrison


Monday, January 28, 2008
Despite regulatory and reimbursement challenges to its erythropoietin stimulating agent (ESA) franchise, Amgen Inc. beat analyst estimates for earnings in the fourth quarter of 2007. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription